Title and Organization:
Dr. David T. Hutchings specializes in geriatric neuropathology and Dementia. He practices as the Chief Operations Officer for Spectramed overseeing the company’s clinical and operational quality. Previously he practiced as the Chief Executive Officer for Stonerise Therapy. Dr. Hutchings is also the founder of Dementia and Alzheimer’s Care, LLC a private practice firm focused on the evaluation, treatment and clinical education of all forms of dementia.
Dr. Hutchings graduated with a Bachelors degree from the University of Mississippi with a Masters degree from University of Central Missouri and completed his doctorate from Nova Southeastern University with a specialization of geriatric neuropathology.
Dr. Hutchings has conducted multiple national lectures in geriatrics and dementia. For nearly two decades his clinical practice and research has led to multiple keynote lectures at state and national organizations as well as other venues including Duke University, Vanderbilt University, Northwestern, Auburn University, University of Alabama Birmingham among many others. He also has participated in multiple panel discussions in the areas of geriatrics, clinical outcomes, dementia and neuropathology.
Dr. Hutchings has been published in clinical publications and peer reviewed journals. As a national recognized lecturer, he has conducted multiple key note lectures and in 2013 he developed clinical education articles on Amyotrophic Lateral Sclerosis (ALS) for the CNN network. In 2019, he was featured for the entire month of August on News Channel 5 in Nashville discussing Alzheimer’s and other forms of dementias as well as current research.
In 2018, Dr. Hutchings completed a two-year fellowship with the Aspen Institute which is focused on improving health care globally through policy and practice. The Health Innovators Fellows are an elite group comprised of the top medical practitioners internationally who work to improve healthcare and healthcare delivery.